CVS Health Price Prediction and Hype Density Breakdown

CVS -- USA Stock  

USD 70.97  0.20  0.28%

Macroaxis is not in business of monitoring CVS Health headlines and social sentiment data; there are plenty of companies out there that do it quite successfully. However, we do analyze noise-free headlines and recent hype associated with CVS Health Corporation brand which may create opportunities for some arbitrage if properly timed. With CVS Health hype-based prediction module you can estimate the value of CVS Health Corporation from the prospective of CVS Health response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on CVS Health over a specific investment horizon. Check also CVS Health Basic Forecasting Models to cross-verify your projections.
 Time Horizon     30 Days    Login   to change

CVS Health After-Hype Price Density Analysis

 Next price density 
 
Expected price to next headline

CVS Health Estimiated After-Hype Price Volatility

June 20, 2018
70.97
Current Value
70.93
After-hype Price
Target Odds
  
76.96
Upside
CVS Health is not too risky asset. Analysis and calculation of next after-hype price of CVS Health is based on 1 month time horizon.

CVS Health Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.39% 2.01% 0.04%  0.06% 6 Events / Month3 Events / MonthIn about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
70.9770.930.06%
2,010% 

CVS Health Hype Timeline

On 20 of June CVS Health Corporation is traded for 70.97. This company has historical hype elasticity of -0.04 and average elasticity to hype of competition of -0.06. CVS Health Corporation is estimated to decline in value after the next headline with price expected to drop to 70.93. The average volatility of media hype impact on the company stock price is about 2010.0%. The closing price depreciation on the next news is expected to be -0.06% where as daily expected return is currently at 0.39%. The volatility of related hype on CVS Health is about 1415.09% with expected price after next announcement by competition of 70.91. About 86.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.84. Some equities with similar Price to Book (P/B) outperform the market in the long run. CVS Health Corporation has Price/Earnings To Growth (PEG) ratio of 0.82. This company recorded earning per share (EPS) of 6.44. The firm last dividend was issued on 2018-04-20. CVS Health had 2:1 split on 2005-06-07. Considering 30-days investment horizon, the next estimated press release will be in about 6 days.
Check also CVS Health Basic Forecasting Models to cross-verify your projections.

CVS Health Related Hype Analysis

Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
Laboratory Corporation of America Holdings 0.14 5 per month 0.64  0.23  1.65 (1.36)  5.69 
MEDNAX 0.41 6 per month 0.00 (0.14)  1.22 (1.31)  4.91 
Envision Healthcare Corporation(0.17) 6 per month 1.02  0.21  2.52 (1.81)  6.17 
Concord Medical Services Holdings Limited(0.0204) 2 per month 1.09  0.07  2.76 (1.48)  5.78 
Centene Corporation(0.44) 5 per month 0.42  0.38  1.63 (1.28)  3.01 
CVS Health Corporation(0.10) 6 per month 1.69  0.21  3.10 (3.35)  6.46 
Community Health Systems 0.24 5 per month 3.39  0.0056  4.65 (3.06)  13.76 
DaVita(1.03) 4 per month 0.64  0.24  3.06 (1.24)  4.18 
HCA Healthcare(0.45) 5 per month 0.42  0.17  1.14 (0.59)  3.25 
Encompass Health Corporation 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 

Contributor Headline

Latest Prospective on CVS Health
Investors are also interested in
Purchased over 100 shares
Active six days ago
Check also CVS Health Basic Forecasting Models to cross-verify your projections. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.